MTHFR gene A1298C polymorphisms are associated with breast cancer risk among Chinese population: Evidence based on an updated cumulative meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 11, 2015, Pages 20146-20156

  Wang, Yadong ^a,b   Yang, Haiyan ^c   Duan, Guangcai ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Chinese; MTHFR; Polymorphism; Risk

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; GENE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC);

EID: 84954202719     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fodinger M, Horl WH and Sunder-Plassmann G. Molecular biology of 5, 10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13: 20-33.
2. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP and et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
3. Weisberg I, Tran P, Christensen B, Sibani S and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
4. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
5. Zheng W, Chen L and Li D. Association between dietary intake of folate, vitamin B6, B12 & amp; MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci 2014; 30: 106-110.
6. Dumitrescu RG and Cotarla I. Understanding breast cancer risk--where do we stand in 2005? J Cell Mol Med 2005; 9: 208-221.
7. Qi J, Miao XP, Tan W, Yu CY, Liang G, Lu WF and Lin DX. Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Zhonghua Zhong Liu Za Zhi 2004; 26: 287-289.
8. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F and Zheng W. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004; 13: 190-196.
9. Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE and Shen CY. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat 2008; 111: 145-155.
10. Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T and Tajima K. MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet 2009; 54: 414-418.
11. Hua Z, Wang Y, Ni J, Ge F and Zou T. Folic acid, Vitamin B12, MTHFR, MS gene polymorphisms associate with the risk of breast cancer. Modern Oncology 2011; 19: 428-431.
12. Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP and Yu MC. Green tea intake, MTHFR/ TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008; 29: 1967-1972.
13. Kan X, Zou T, Wu X and Wang X. Association between MTHFR Genotype Polymorphism and Breast Cancer Susceptibility in Human Population from Yunnan. Cancer Research on Prevention and Treatment 2007; 34: 716-718.
14. Lin J, Chen S and Li W. Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to breast cancer. Modern Hospital 2010; 10: 15-17.
15. Wu XY, Ni J, Xu WJ, Zhou T and Wang X. Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population. Asian Pac J Cancer Prev 2012; 13: 2199-2206.
16. He JM, Pu YD, Wu YJ, Qin R, Zhang QJ, Sun YS, Zheng WW and Chen LP. Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. Genet Mol Res 2014; 13: 8925-8931.
17. Huang CY, Chang WS, Shui HA, Hsieh YH, Loh CH, Wang HC, Ji HX, Hsiao CL, Hsu CM, Tsai CW and Bau DT. Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast cancer. Anticancer Res 2014; 34: 4109-4115.
18. Liu Y, Zhou LS, Xu XM, Deng LQ and Xiao QK. Association of dietary intake of folate, vitamin B6 and B12 and MTHFR genotype with breast cancer risk. Asian Pac J Cancer Prev 2013; 14: 5189-5192.
19. Lu Q, Jiang K, Li Q, Ji YJ, Chen WL and Xue XH. Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population. Tumour Biol 2015; 36: 3757-3762.
20. Qiao J, Jiao D, Lu Z, Cui S and Liu Z. Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B12 intakes. Tumor Biol 2014; 35: 11895-11901.
21. Wang L, Jiang Z, Qiu H, Tang W and Duan T. Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies. Int J Clin Exp Med 2015; 8: 6835-6851.
22. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
23. Begg CB and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
24. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
25. Liang H, Yan Y, Li T, Li R, Li M, Li S and Qin X. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumour Biol 2014; 35: 1695-1701.
26. Song S, Yang B and Sun G. The correlation between the 5, 10-methylenetrahydrofolate reductase C677T or A1298C polymorphisms and breast cancer risk in China: a Metaanalysis. Chin J Prev Contr Chron Dis 2013; 21: 560-564.
27. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY and Sun CA. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 2006; 27: 2295-2300.
28. Salanti G, Amountza G, Ntzani EE and Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005; 13: 840-848.